E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/16/2013 in the Prospect News PIPE Daily.

Oncosec sells $11.95 million registered public sale of units at $0.25

Company sells units with half-share warrants through H.C. Wainwright

By Devika Patel

Knoxville, Tenn., Sept. 16- Oncosec Medical Inc. said it priced an $11.95 million registered public offering of units.

The company will sell 47,792,000 units of one common share and one half-share warrant at $0.25 per unit, with each whole warrant exercisable at $0.35 for four years. The strike price is a 9.38% premium to the Sept. 13 closing share price of $0.32.

H.C. Wainwright & Co., LLC is the agent.

Settlement is expected Sept. 19.

Proceeds will be used for general corporate purposes, including clinical trial expenses and research and development expenses.

The biomedical company is based in San Diego.

Issuer:Oncosec Medical Inc.
Issue:Units of one common share and one half-share warrant
Amount:$11,948,000
Units:47,792,000
Price:$0.25
Warrants:One half-share warrant per unit
Warrant expiration:Four years
Warrant strike price:$0.35
Agent:H.C. Wainwright & Co., LLC
Pricing date:Sept. 16
Settlement date:Sept. 19
Stock symbol:OTCBB: ONCS
Stock price:$0.32 at close Sept. 13
Market capitalization:$30.98 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.